Clinical Trials Directory

Trials / Completed

CompletedNCT04172857

Treatment of Malignant Glaucoma by Anterior Vitrectomy From Two Different Approaches

Treatment of Malignant Glaucoma Secondary to Cataract Surgery Combined With Goniosynechialysis by Anterior Vitrectomy From Two Different Approaches

Status
Completed
Phase
Study type
Observational
Enrollment
9 (actual)
Sponsor
Wenzhou Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To compare the surgical outcomes of treating phacoemulsification with intraocular lens implantation combined with goniosynechialysis (Phaco-IOL-GSL) associated malignant glaucoma (MG), using different incision sites in anterior vitrectomy combined with hyaloidotomy, zonulectomy, and iridectomy (VHZI).

Conditions

Interventions

TypeNameDescription
PROCEDUREanterior vitrectomy combined with hyaloidotomy, zonulectomy and iridectomyFirst, a 23-G incision was made at the peripheral inferior temporal sector of the cornea and connected with an anterior chamber infusion cannula. Another corneal incision was made at the superior temporal sector or superior nasal sector, and Viscoat® (Bausch \& Lomb, Shandong, China) was infused though the incision to fill the anterior chamber. Iridotomy was performed through the incision using Wescott scissors and toothed forceps. Hyaloidectomy and zonulectomy were performed through a peripheral iris defect using an anterior chamber approach to set up a pathway between the anterior chamber and the vitreous cavity. We repeatedly carried out vitrectomy around the pathway to reduce the risk of postoperative re-obstruction of the tunnel created.

Timeline

Start date
2015-05-01
Primary completion
2019-01-20
Completion
2019-01-30
First posted
2019-11-21
Last updated
2019-11-21

Source: ClinicalTrials.gov record NCT04172857. Inclusion in this directory is not an endorsement.